0
0
10/24/23 at 1:24pm
Organization
The Washington Post
Author
Sabrina Malhi
36 words
0
Comments
The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
You are the first to view
https://www.washingtonpost.com/health/2023/10/24/rsv-monoclonal-shortage-cdc-update/
Create an account
or login to join the discussion